UroGen Pharma (URGN) Selling, General & Administrative (2016 - 2026)
UroGen Pharma (URGN) posted Selling, General & Administrative of $48.44 million for Q2 2026, up 12.1% from $43.2 million a year earlier but down 5.9% from the prior quarter.
Powered by 
Analysis
UroGen Pharma (URGN) Selling, General & Administrative (2016 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Selling, General & Administrative at UroGen Pharma was $176.85 million, up 24.6% year-over-year; for FY2025, it came in at $155.1 million, up 28.0% from FY2024.
- Annual Selling, General & Administrative has increased for three consecutive years, with a five-year compound annual growth rate of 11.4% (FY2020 to FY2025).
- In prior years, UroGen Pharma's Selling, General & Administrative was $121.15 million in FY2024 (+29.9%), $93.27 million in FY2023 (+12.6%), $82.84 million in FY2022 (-5.4%) and $87.54 million in FY2021 (-3.0%).
- Quarterly Selling, General & Administrative has run from a low of $19.07 million in Q3 2022 to a high of $51.49 million in Q1 2026 over five years.
- On a year-over-year basis, Selling, General & Administrative has increased in each of the last 15 quarters, with growth averaging 31.1% over the last eight quarters.
- The strongest year-over-year quarter for Selling, General & Administrative in the past five years was Q1 2026, with growth of 47.2%; the weakest was Q3 2022, with a decline of 11.8%.
- According to Business Quant data, Selling, General & Administrative for the three prior quarters was $51.49 million (Q1 2026), $39.35 million (Q4 2025) and $37.58 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 3.13 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 6.29 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 4.09 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 2.89 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 5.11 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 1.68 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.64 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 3.28 Bn |
| 10 | UroGen Pharma | 1.24 Bn | 782.15 Mn | 81.50 Mn | 47.21 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 47.21 Mn |
| Jun 30, 2026 | 48.44 Mn |
| Mar 31, 2026 | 51.49 Mn |
| Dec 31, 2025 | 39.35 Mn |
| Sep 30, 2025 | 37.58 Mn |
| Jun 30, 2025 | 43.20 Mn |
| Mar 31, 2025 | 34.97 Mn |
| Dec 31, 2024 | 34.86 Mn |
| Sep 30, 2024 | 28.94 Mn |
| Jun 30, 2024 | 30.06 Mn |
| Mar 31, 2024 | 27.30 Mn |
| Dec 31, 2023 | 24.55 Mn |
| Sep 30, 2023 | 21.76 Mn |
| Jun 30, 2023 | 22.49 Mn |
| Mar 31, 2023 | 24.47 Mn |
| Dec 31, 2022 | 21.63 Mn |
| Sep 30, 2022 | 19.07 Mn |
| Jun 30, 2022 | 20.83 Mn |
| Mar 31, 2022 | 21.30 Mn |
| Dec 31, 2021 | 21.42 Mn |
API Access
UroGen Pharma Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=URGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "URGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=URGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();